Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Risks must be balanced

  1. Ann F Bisset, medical adviser. (ann.bisset@virgin.net)
  1. Public Health Medicine, Information and Statistics Division, Edinburgh EH5 3SQ
  2. Public Health Medicine, Information and Statistics Division, Edinburgh EH5 3SQ
  3. Department of Psychological Medicine, Meadowbrook Unit, Salford M6 8HG

    EDITOR —Until the Committee on the Safety of Medicines restricted the use of thioridazine in 2000, it was the most widely used antipsychotic drug in the United Kingdom, with 50 million years of safe use by patients worldwide. In Scotland in 1999, were 250 808 were prescriptions dispensed in primary care (hospital data not available, but the safety committee reports that it was the most widely used antipsychotic drug in hospitals too). This dropped to 39 177 in 2001, according to information from the Primary Care Information Unit in Edinburgh.

    Is thioridazine safer, cheaper, and more effective than alternative antipsychotic drug treatments for anxiety, agitation, mania, and hypomania? We do not have enough evidence to answer this because thioridazine has been widely used for 30 years—before the days of rigorous randomised controlled trials. Lack of evidence is not evidence of no benefit. Conversely, there is only evidence of a handful of …

    Access to the full text of this article requires a subscription or payment

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    THIS WEEK'S POLL